Li Junjie

Associate Professor (Special Project)

Kyushu University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Drug Delivery Drug Delivery professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Li Junjie is an Associate Professor (Special Project) at Kyushu University, Japan. His research areas include nanomedicine, cellular senescence, and cancer therapy, as reflected in his recent publications on targeted nanodrugs, antioxidative nanoreactors, and the application of nanocarriers in various medical contexts. He actively explores innovative approaches to combat liver diseases and enhance cancer treatment through advanced nanotechnology.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Satoshi Uchida

Tokyo Medical and Dental University

JAPAN

View details

Kazunori Kataoka

Professor Emeritus

University of Tokyo

JAPAN

View details

Joachim F. R. Van Guyse

Assistant professor

Leiden University

NETHERLANDS

View details

Yuki Mochida

Junior Associate Professor

Tokyo Medical and Dental University

JAPAN

View details

Yasutaka Anraku

Associate Professor

Tokyo Institute of Technology

JAPAN

View details

Masaru Tanaka

Kyushu University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Li Junjie

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Reprogramming cellular senescence of hepatic stellate cells to combat liver fibrosis by targeted nanodrugs

Structural stability and RNase resistance of mRNA Polyplex micelles for systemic delivery

Engineering durable antioxidative nanoreactors as synthetic organelles for autoregulatory cellular protection against oxidative stress

NIR-activatable aza-BODIPY nanoparticles for photoacoustic imaging and synergistic NO–photothermal cancer therapy

Regulating tumor innervation by nanodrugs potentiates cancer immunochemotherapy and relieve chemotherapy-induced neuropathic pain

Facile Generation of Heterotelechelic Poly(2‐Oxazoline)s Towards Accelerated Exploration of Poly(2‐Oxazoline)‐Based Nanomedicine

Facile Generation of Heterotelechelic Poly(2-Oxazoline)s Towards Accelerated Exploration of Poly(2-Oxazoline)-Based Nanomedicine

Leveraging adrenergic receptor blockade for enhanced nonalcoholic fatty liver disease treatment via a biomimetic nanoplatform

Stealth and pseudo-stealth nanocarriers

Stealth and pseudo-stealth nanocarriers

Controlling the biodistribution and clearance of nanomedicines

Effective mRNA Protection by Poly(L-Ornithine) Synergizes with Endosomal Escape Functionality of a Charge-Conversion Polymer Toward Maximizing mRNA Introduction Efficiency

Targeted nanomedicine in cisplatin-based cancer therapeutics

Enzymatically Transformable Polymersome‐Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer

Hypoxia-responsive block copolymer polyprodrugs for complementary photodynamic-chemotherapy

Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy

Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation

Self‐Boosting Catalytic Nanoreactors Integrated with Triggerable Crosslinking Membrane Networks for Initiation of Immunogenic Cell Death by Pyroptosis

Self‐Boosting Catalytic Nanoreactors Integrated with Triggerable Crosslinking Membrane Networks for Initiation of Immunogenic Cell Death by Pyroptosis

Collaborators (6)

Satoshi Uchida

Kazunori Kataoka

Joachim F. R. Van Guyse

Yuki Mochida

Yasutaka Anraku

Masaru Tanaka

Make your next move.